In the present study, ESCC patients in the TCGA-ESCA cohort with tumors overexpressing COX6C, AZIN1-AS1, PVT1, and MMP12 might to be associated with poor disease-free survival in TCGA-ESCA patients. This evidence concerns the gene COX6C and esophageal squamous cell carcinoma.